Factors associated with sleep disturbances in children and adolescents with Angelman Syndrome.
Geraldine Leader, Chloe Killeen, Sally Whelan...
https://pubmed.ncbi.nlm.nih.gov/38479041/Actively Recruiting
Led by Foundation for Angelman Syndrome Therapeutics, Australia · Updated on 2026-09-03
5000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are collecting information through the Global Angelman Syndrome Registry to better understand the natural history of children and adults living with Angelman Syndrome. This online patient organization-driven registry aims to support the recruitment for clinical trials of therapies and interventions that may help individuals with Angelman Syndrome and their families. It also seeks to promote research and improve standards of care for this condition. The registry is accessible in multiple languages including English, Spanish, Traditional Chinese, Italian, Polish, Hindi, and Brazilian Portuguese. It is an observational study, meaning that it collects data without administering any treatments or interventions. Participants from birth through adulthood with Angelman Syndrome can join the registry. Participants provide information over the course of their lifespan, up to 70 years, to help researchers gather long-term data. This may include completing questionnaires and sharing medical and personal health information online. The registry is designed to facilitate ongoing research and clinical trial recruitment, with no active treatment or study visits required. Participants can remain involved for many years to support a better understanding of Angelman Syndrome.
CONDITIONS
The Global Angelman Syndrome Registry
M
Megan Tones
N
Niki Armstrong
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Foundation for Angelman Syndrome Therapeutics, Australia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 online registration and eligibility check
Duration - Up to 70 years (lifespan)
Participants provide health and personal information over time through an online registry without receiving treatment.
Periodic online questionnaires and updates
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Geraldine Leader, Chloe Killeen, Sally Whelan...
https://pubmed.ncbi.nlm.nih.gov/38479041/Geraldine Leader, Rebecca Gilligan, Sally Whelan...
https://pubmed.ncbi.nlm.nih.gov/35797778/Darragh S O'Donohoe, Sally Whelan, Arlene Mannion...
https://pubmed.ncbi.nlm.nih.gov/39222563/Kathryn R Napier, Megan Tones, Chloe Simons...
https://pubmed.ncbi.nlm.nih.gov/28764722/Megan Tones, Nikolajs Zeps, Yvette Wyborn...
https://pubmed.ncbi.nlm.nih.gov/37858180/G Leader, S Whelan, N N Chonaill...
https://pubmed.ncbi.nlm.nih.gov/36052644/M Tones, M Cross, C Simons...
https://pubmed.ncbi.nlm.nih.gov/29633452/Foundation for Angelman Syndrome Therapeutics, Australia
Lead Sponsor